Oncotarget (IMAGE) Impact Journals LLC Caption Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer Credit 2024 Tolmeijer et al. Usage Restrictions Original Content License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.